Thomson Reuters and Health Care Systems, Inc (HCS) today announced an integration agreement that gives hospitals, ambulatory clinics, and physician practices more options in how they use Thomson Reuters Micromedex drug and patient education reference information.
Under the agreement, evidence-based information from Micromedex will now be available with most core HIS, Physician Practice Management and Ambulatory EMR vendor architectures.
"Integration with an organization's core Health Care Information System supports clinicians' ability to provide clinically consistent education materials across their healthcare enterprise." said Thomas Hegelund, executive vice president at Thomson Reuters.
The new integration options give hospitals design flexibility in how they provide Micromedex content to clinicians and patients. Hospitals will have ability to store CareNotes(R) patient education documents in their electronic medical records, and provide them directly to patients.
The solution addresses the Meaningful Use Core Objective for electronic patient discharge instructions. CareNotes patient education materials for this solution are available in 15 languages.
In addition to integrating Micromedex content into most major healthcare information systems, HCS also will integrate Micromedex content directly into its own Medication Reconciliation solution. The HCS Medication Reconciliation solution addresses a critical element of meaningful use compliance, and will use Micromedex content for both drug-interaction checking and patient education.
"HCS is pleased to work with Thomson Reuters to provide clinicians with easily accessible, aggregated patient education based on the patient's medications, diagnoses, and lab results with a single click or keystroke," said Dwight Henderson, president of HCS. "Providing the capability to generate patient education as part of the clinician's workflow within their clinical information system supports meaningful use, saves time and improves patient care. We are also excited about integrating Thomson-Reuters Micromedex education into HCS's clinical systems."
For more information, please visit www.micromedex.com.
About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.